Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Zimmer
Acquired Company
Capra Biosciences, Inc
WarsawCaliforniaManufacturingInformation TechnologyBiotechnologyHealth CareArtificial IntelligenceMedicalMedical Devicemedical devicesBiotechnologyHealth CareMedical DeviceDescription
On June 28, 2026, Pacira Biosciences, Inc. entered into a Stock and Asset Purchase Agreement with Zimmer, Inc. to divest its wholly owned subsidiary, Pacira CryoTech, Inc. The agreement entails the sale of all outstanding capital stock of the subsidiary along with certain assets and liabilities related to its handheld cryoanalgesia devices. The total transaction value is up to $140 million, with an upfront payment of $70 million.
Fundz sees it the moment Zimmer makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Capra Biosciences, Inc?
Capra Biosciences, Inc was acquired by Zimmer, based in Warsaw. The deal was reported on June 30, 2026. Zimmer, Inc. is a subsidiary of Zimmer Biomet Holdings, Inc., specializing in orthopedic reconstructive products and related services. Zimmer is publicly traded (ZBH) and operates in Manufacturing.
When did Zimmer acquire Capra Biosciences, Inc?
Zimmer's acquisition of Capra Biosciences, Inc was reported on June 30, 2026. On June 28, 2026, Pacira Biosciences, Inc. entered into a Stock and Asset Purchase Agreement with Zimmer, Inc. to divest its wholly owned subsidiary, Pacira CryoTech, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Capra Biosciences, Inc do?
Pacira CryoTech, Inc. is a wholly owned subsidiary of Pacira Biosciences, Inc. that specializes in handheld cryoanalgesia devices and related products. The company is known for its flagship device, iovera®°, which provides non-opioid pain management solutions. It is privately held, operating in Biotechnology, and is based in California.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.